Cargando…

Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood

Objective. Anticyclic citrullinated peptide antibodies (anti-CCP) testing is useful in the diagnosis of rheumatoid arthritis (RA) with high specificity. Arthritis is a very common clinical manifestation in children with familial Mediterranean fever (FMF). The aim of the study was to show the presenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onur, Hatice, Aral, Hale, Arica, Vefik, Bercem, Gamze, Usta, Murat, Kasapcopur, Özgur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782833/ https://www.ncbi.nlm.nih.gov/pubmed/24106502 http://dx.doi.org/10.1155/2013/498581

Ejemplares similares

Vitamin D levels in children with familial Mediterranean fever
por: Onur, Hatice, et al.
Publicado: (2016)

P01-019 – Anti-CCP antibodies are not associated with FMF
por: Onur, H, et al.
Publicado: (2013)

P01-016 – Decreased vitamin D levels in FMF patients
por: Onur, H, et al.
Publicado: (2013)

Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
por: Barut, Kenan, et al.
Publicado: (2014)

Articular involvement in childhood Familial Mediterranean Fever
por: Barut, K, et al.
Publicado: (2015)

Familial Mediterranean Fever in childhood: a single center experience
por: Barut, K, et al.
Publicado: (2015)

Comparison of Quantiferon Test with Tuberculin Skin Test for the Detection of Tuberculosis Infection in Children
por: Onur, Hatice, et al.
Publicado: (2012)

Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever
por: Yucel, Ilker Kemal, et al.
Publicado: (2011)

Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
por: Berdeli, Afig, et al.
Publicado: (2019)

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
por: Gül, Ahmet, et al.
Publicado: (2015)

Anti-CCP antibodies and bone
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever
por: Kirectepe, Asli K, et al.
Publicado: (2011)

Development of acute dystonia in three brothers due to metoclopramide
por: Silfeler, Ibrahim, et al.
Publicado: (2012)

Increased Frequency of Febrile Seizures in Two Periodic Fever Syndromes: Familial Mediterranean Fever and PFAPA Syndrome
por: Kılıç, Hüseyin, et al.
Publicado: (2022)

Author's Reply, Malondialdehyde Level in the Cord Blood
por: Arica, Vefik
Publicado: (2012)

Pediatric neurobrucellosis associated with hydrocephalus
por: Altas, Murat, et al.
Publicado: (2010)

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

Screening of free carnitine and acyl-carnitine status in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
por: Polat, Adem, et al.
Publicado: (2014)

Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever
por: Piskin, David, et al.
Publicado: (2022)

Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays
por: Vos, Ine, et al.
Publicado: (2017)

Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis
por: Ediz, Levent, et al.
Publicado: (2011)

Endoscopic Findings of Children with Familial Mediterranean Fever
por: Sağ, Elif, et al.
Publicado: (2018)

The association of anti-CCP antibodies with disease activity in rheumatoid arthritis
por: Serdaroğlu, Münevver, et al.
Publicado: (2008)

The clinical significance of anti-CCP antibodies in Korean JRA patients
por: Kim, Kwang Nam, et al.
Publicado: (2014)

Identification of CCp5 and FNPA as Novel Non-canonical Members of the CCp Protein Family in Babesia bovis
por: Ozubek, Sezayi, et al.
Publicado: (2022)

Familial Mediterranean Fever without Fever
por: Hotta, Yuma, et al.
Publicado: (2020)

Remission of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment
por: Odabas, Hatice
Publicado: (2006)

Intrathoracic Rib Associated with Pulmonary Collapse in a Pediatric Patient
por: Basarslan, Fatmagul, et al.
Publicado: (2012)

Relation Between Anti-CCP Antibodies and Sharp Score in Rheumatoid Arthritis
por: Mekic, Mevludin, et al.
Publicado: (2020)

Assessment of Surrogate Markers for Cardiovascular Disease in Familial Mediterranean Fever-Related Amyloidosis Patients Homozygous for M694V Mutation in MEFV Gene
por: Sahin, Sezgin, et al.
Publicado: (2022)

Ultrasonographic evaluation of femoral cartilage thickness in patients with familial Mediterranean fever
por: Aydemir Ekim, Ayşe, et al.
Publicado: (2021)

Malondialdehyde Level in the Cord Blood of Newborn Infants
por: Gülbayzar, Sayat, et al.
Publicado: (2011)

The Characteristics of Pediatric Patients with Familial Mediterranean Fever Treated with Anti-Interleukin-1 Treatment
por: Avar Aydın, Pınar Özge, et al.
Publicado: (2022)

Familial Mediterranean Fever and Hypercoagulability
por: Tayer-Shifman, Oshrat E., et al.
Publicado: (2011)

An Update on Familial Mediterranean Fever
por: Lancieri, Maddalena, et al.
Publicado: (2023)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Severity and frequency of restless legs syndrome in patients with familial Mediterranean fever
por: Yılmaz, Samet, et al.
Publicado: (2017)

Relationship between circulating microparticles and hypertension and other cardiac disease biomarkers in the elderly
por: Usta Atmaca, Hanife, et al.
Publicado: (2019)

Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab
por: Barut, K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tp39pdel35qqbmmvcbo84c8jop